VP, Global Medical Lead - Vaccines

GSK•Upper Providence, PA

1d•Hybrid

About The Position

The VP, Global Medical Lead (GML) mRNA portfolio, is a key senior business leadership role, reporting to the SVP, Global Medical Vaccine Head. This is a new GML role created due to a Commit to Phase 3 decision in Q2 2026. The leader will have full responsibility for the Global Medical Strategy for the mRNA Flu, Covid and Combination portfolio. They will lead the translation of our science to shape the practice of medicine and deliver positive health impact for patients by providing healthcare decision-makers around the world with the evidence and confidence they need on GSK therapies/Vaccines and influencing internal stakeholders with medical insight and expertise related to Development and Commercialization strategies. The role will be accountable for the Medical strategic direction of the portfolio and the matrix leadership of the Global Asset/Vaccine Medical Leadership Team, integrating innovative strategies that support future product launches and advance patient care and help shape the practice of medicine. The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/vaccine development and strategic deliverables as well as partnering across Commercial and R&D to deliver value for patients. In addition to leading the Global Asset Medical Leadership team, the incumbent will be a member of several additional matrix teams including the Medicines/Vaccine Development Team and the Medicine/Vaccine Commercial Team where they will provide Medical insight and expertise to inform and influence the integrated evidence strategy and scientific communication plans across the lifecycle to optimize patient impact within markets. A key focus of the role is to develop and stretch self and team to be best in industry at delivering impact for patients and improving patient care paradigms. The leader must exemplify GSK values and leadership behaviours.

Requirements

MD/MBBS/PharmD or PhD in clinical / scientific discipline related to medicine/pharmacology
Experience in a global medical affairs role leading a launch asset
Experience in a medical affairs leadership role in country; either as a Country Medical Director in a smaller market or a Therapy Area Lead in a larger market
Clinical development experience
Experience supporting an indication as part of a cross functional team including creation of a competitive and accessible TPP
Experience in medical support for briefing documents for regulatory interactions and payor dossiers
General understanding of statistics, safety, regulatory requirements

Nice To Haves

Strong preference for prior US experience
Strong demonstration of strategic and medical leadership and scientific agility
Track record of building and maintaining a deep and continued connection to medical practice and healthcare delivery
Experience of launching medicines or vaccines either at global or local level
Examples of curiosity and agility with the ability to pivot to new areas of focus, assimilate information rapidly and identify critical questions that will drive decision-making and planning
Skilled at simultaneous consideration of scientific data and practical healthcare delivery needs from diverse health systems to optimise medical implementation of innovation.
Evidence of innovative digital and AI leadership within prior medical roles
Collaborative matrix management skills with a focus on leading diverse groups (e.g., cultural, geographical, functional) to achieve excellent results in shared goals.
Strong listening, communication & collaborative team working and leadership skills, as the role involves interface with a wide range of stakeholders internally and externally.
Examples of where cross-functional collaboration and ability to influence various stakeholders across different levels in the matrix organisation has been harnessed.
Demonstrated deep relationships and interaction with external experts (physicians) in the therapeutic area - requiring a high level of medical knowledge/experience, understanding of patient management, and strong clinical judgement on benefit- risk significance
Impactful communication and influencing skills with the ability to distil complexity down to what matters most to our stakeholders.
Ability to manage ambiguity, evaluate benefit and risk and take appropriate accountability for decision making - enterprise leader with business acumen and agility to create business outputs in a VUCA (Volatility, Uncertainty, Complexity, Ambiguity) environment.
Strong financial/budget and project management skills as well as business acumen.
Maintenance of high professional standards and adherence to internal and external codes of practice
Ability to prioritise work for self and team

Responsibilities

Lead both the cross-functional global medical team (GMT) and oversee global medical portfolio budget
As convenor and chair of the GMT Jointly accountable with, top tier markets, for developing the global medical brand strategy and plans by convening the GMT
Set direction along strategic framework of the medical brand plan including setting scientific objectives, own the medical scientific narrative and the integrated communication plan
Accountable for directing and coordinating global resources to generate data and create content to support priority markets, leveraging the expertise of the Global data generation and scientific communication teams
Represent medical as independent strategic partner in cross-functional strategy meetings and proactively offer options for innovative medical strategies
Provide focused input at key inflection points during development (e.g., from commit to Phase 2 onwards and throughout the Lifecyle)
As Lead of the cross-functional GMT for mRNA Responsible for representing the voice of the CPO organisation
Accountable for all medical activities related to mRNA portfolio development at the global level
Lead, coach, and mentor direct reports that support the GMT in development of medical brand strategy and plans, and execute and/or support execution of global tactics
Address broader holistic disease area considerations as they arise by convening other relevant GMLs ad-hoc
Play an active role within TA to articulate and implement a single, unified medical strategy across portfolio
Maximize the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation potential).
Act as a partner to the Vaccine Development Lead and Vaccine Commercialisation Lead, ensure integrated and thoughtful insights from across a diverse stakeholder set to contribute to shaping the medicines/vaccine’s vision, development strategy and clinical development in the early phases of development, as well as for refining medical strategy as clinical evidence is generated.
Ensure that medical insights from the priority markets are incorporated into the GMT to inform all evidence, product development, and asset strategy deliverables.
Accountable for leading the GMT in the development and delivery of the Global medical product strategy and associated global deliverables enabling prioritized LOCs to execute the strategy and deliver positive patient impact locally.
Ensure that the data generation plan aligns to identified unmet needs and prioritized evidence gaps and addresses key medical and market access requirements, maximizing the asset competitiveness from launch through lifecycle management for priority markets
Lead a global matrix team that executes on generation of evidence, publication plans and creation of content to support the priority markets to shape the practice of medicine and differentiate our medicines and vaccines.
Act as medical Launch lead, partnering with cross-functional partners and priority markets to ensure timely and ambitious launches
Input into the cross-functional team, in partnership with the VDL and VCL for the development of ambitious LCI plans
Lead regular assessment of medical plan impact utilizing the medical impact framework, ensuring plan reviews and proactive communication of impact measures to key stakeholders as required
Oversee asset budget to ensure that resources are deployed against the highest the highest impact tactics
Ensure that Global deliverables are produced on time based on market needs
Use a Global mindset, incorporating local perspectives, to strategy development and decision making.
Partner with priority markets to understand their needs and balance options to achieve the set-out goals.
Maintains the patient at the center of everything we do.
Full immersion in the science, disease area and business to be a true and equal partner to R&D, Commercial and Key LOCs.
Maintain up to date knowledge of scientific data and competitive intelligence and drive transformation of knowledge and medical insights into patient-centered strategic thinking and action plans
Outstanding matrix leadership through the creation of a collaborative and cross-functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects and encouraging employees to work with diverse skill sets and learn from each other.
Seek out, actively listen to and understand the needs of key markets and ensure they are appropriately reflected in the global strategy, inclusive of evidence generation and all other deliverables.
Assess and understands the external environment, inclusive of the competitor landscape, to bring insights together to develop a clear, simple, compelling Medical strategy to improve outcomes for patients
Adopt a visionary and intuitive mindset, to anticipate current and future market value-drivers and evidence gaps and seek innovative solutions to them to support the long-term ambition for the asset/vaccine and its ultimate benefit for patients
Quickly adapt to unexpected external changes, understanding impact to strategy and ability to articulate implications for both R&D and commercial
Integrate and synthesize deep understanding of the end-to-end asset development processes, inclusive of commercialization and interconnectivities to deliver practice change and impact for patients
Be a role model to all GSK employees, setting the right tone from the top while embedding a culture of performance underpinned by GSK Purpose, strategy and culture.
Visibly leads with authenticity and confidence to gain followship for a workable plan, even in ambiguity.
Creates cohesion and fellowship amongst the Medical Asset/Portfolio Leadership Team, especially with key/priority LOCs, maximizing its effectiveness as a decision-making unit, external impact and fostering collective accountability for success.
Communicates consistently and with impact, with the goal that everyone who works on an asset understands and can implement the strategy.
Adapt approaches for seeking input and feedback to accommodate cultural differences in LOCs.
Outstanding leader of people, directly and indirectly, creating clarity in expectations and holding oneself and team accountable
Creates an environment where our people can develop and thrive while holding a high-performance bar across organization which he/she leads
Identify, attract, develop and retain talent and organizational capability for the future
Leads through uncertainty and ambiguity driving a culture of continuous improvement while building an agile learning organization
Manage corporate reputation & builds trust
Builds strong relationships across the enterprise to maximize synergies and impact
Fully understands the GSK Code and relevant policies governing our work enabling team members and self to always do the right thing
Understands and proactively identifies risk developing mitigation plans aligned to our Internal Control Framework
Develop, gain approval for, and manage the annual budget required to deliver the objectives for in line with defined processes and policies